Zanubrutinib is a highly selective and potent BTK inhibitor that has demonstrated significant efficacy in various B-cell lymphomas, such as mantle cell lymphoma and chronic lymphocytic leukemia.
Zanubrutinib在B细胞淋巴瘤中的应用
本文深入探讨Zanubrutinib作为一种高选择性BTK抑制剂在B细胞淋巴瘤中的显著疗效，包括套细胞淋巴瘤和慢性淋巴细胞白血病，基于2025最新临床研究数据。
与梅斯小智对话
